Ferrophilic Characteristics of Vibrio vulnificus and Potential Usefulness of Iron Chelation Therapy
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
We determined the ferrophilic characteristics of Vibrio vulnificus to evaluate the potential usefulness of iron chelation therapy for the prevention of V. vulnificus infection. Readily available non-transferrin-bound iron (NTBI) is required for the initiation of V. vulnificus growth under in vitro iron-limited conditions and human ex vivo conditions. NTBI aided efficient transferrin-bound iron (TBI) use by V. vulnificus, and the vulnibactin-mediated iron-uptake system was expressed after bacterial growth had been started by NTBI. V. vulnificus required higher NTBI levels for the initiation of growth, produced siderophores at lower levels, and used TBI less efficiently than other bacteria. In addition, the growth of V. vulnificus was inhibited by deferiprone, a clinically available iron chelator. These results show that V. vulnificus is a ferrophilic bacterium that requires higher NTBI levels than other pathogens and that iron chelation therapy might be an effective means of preventing the in vivo growth of V. vulnificus in susceptible patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NTBI was shown to promote the growth of V. vulnificus in cirrhotic ascites (Kim et al., 2007) even better than holotransferrin.”
From Hepcidin-Induced Hypoferremia Is a Critical Host Defense Mechanism against the Siderophilic Bacterium Vibrio vulnificus (2015) · cites this paper as Kim et al., 2007
Citations
Cites
Ferrozine---a new spectrophotometric reagent for iron
Stookey, L. L. (1970) · Analytical Chemistry · doi:10.1021/ac60289a016 · Cited by 4,661 · cited 1×
“The residual iron concentration of deferrated (DF)‐HI broth, measured using the method of Stookey [ 25 ], was ∼1 mmol/L.”
MethodA short course in bacterial genetics
Miller, J. H. (1992) · Cited by 4,511
Andrews, S. C., Robinson, A. K., & Rodríguez-Quiñones, F. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00055-x · Cited by 2,702 · cited 3×
“Accordingly, it is likely that an increased transferrin iron saturation increases iron availability, lowers the antimicrobial activity of transferrin, and eventually increases host susceptibility [3-5].”
BackgroundMiller, V. L., & Mekalanos, J. J. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.6.2575-2583.1988 · Cited by 2,126 · cited 1×
“coli SY327 Xpir and SM10 Xpir [21] and transferred to V vulnificus CMM2101 by conjugation.”
BackgroundIron Metabolism in Pathogenic Bacteria
Ratledge, C., & Dover, L. G. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.881 · Cited by 1,539 · cited 2×
“Accordingly, it is likely that an increased transferrin iron saturation increases iron availability, lowers the antimicrobial activity of transferrin, and eventually increases host susceptibility [3-5].”
BackgroundRole of iron in the pathogenesis of Vibrio vulnificus infections
Wright, A. C., Simpson, L. M., & Oliver, J. D. (1981) · Infection and Immunity · doi:10.1128/iai.34.2.503-507.1981 · Cited by 343 · cited 4×
“Iron plays a pivotal role in the pathogenesis of V vulnificus infection [14-18].”
BackgroundInfluentialFarinha, M. A., & Kropinski, A. M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.6.3496-3499.1990 · Cited by 277 · cited 1×
“Pvuu,,A::lacZ transcriptional fusion was constructed using pQF52 that contained a promoterless lacZ gene [23].”
MethodIron and infection: the heart of the matter
Bullen, J. J., Rogers, H. J., Spalding, P. B., & Ward, C. G. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.010 · Cited by 273 · cited 2×
“Accordingly, it is likely that an increased transferrin iron saturation increases iron availability, lowers the antimicrobial activity of transferrin, and eventually increases host susceptibility [3-5].”
Background(2005) · PubMed · Cited by 246
The detection of four molecular forms of human transferrin during the iron binding process
Makey, D. G., & Seal, U. S. (1976) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(76)90270-1 · Cited by 232 · cited 1×
“Accordingly, 6 mol/L urea gel electrophoresis was used to monitor iron removal from transferrin during culture, as described by Makey and Seal [30].”
Method
Cited by
Vibrio vulnificus: Disease and Pathogenesis
Jones, M. K., & Oliver, J. D. (2009) · Infection and Immunity · doi:10.1128/iai.01046-08 · Cited by 720
“vulnificus growth; therefore, HupA may be necessary for initial growth once the organism enters the host (60, 92).”
BackgroundHorseman, M. A., & Surani, S. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.11.003 · Cited by 343
Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P. A., Ganz, T., Nemeth, E., & Bulut, Y. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.12.001 · Cited by 227
“NTBI was shown to promote the growth of V. vulnificus in cirrhotic ascites (Kim et al., 2007) even better than holotransferrin.”
BackgroundInfluentialOptical sensor: a promising strategy for environmental and biomedical monitoring of ionic species
Saleem, M., & Lee, K. H. (2015) · RSC Advances · doi:10.1039/c5ra11388a · Cited by 229
Advances in iron chelation: an update
Heli, H., Mirtorabi, S., & Karimian, K. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.569493 · Cited by 102
“vulnificus remain difficult infections to treat, especially in splenectomized thalassemia major patients [404,405].”
BackgroundAlice, A. F., Naka, H., & Crosa, J. H. (2008) · Infection and Immunity · doi:10.1128/iai.00208-08 · Cited by 70
“(22) showed that nontransferrin-bound iron is required for the initiation of V.”
BackgroundIn Vivo Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus Sepsis
Jang, H., Choi, S., Kim, H. K., Kim, S., Kang, S., Park, K., Ryu, P. Y., Lee, T., Kim, Y. R., Rhee, J. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101118 · Cited by 52
“therapies [17,18] and more effective antibiotic regimens.”
A Widespread Deferoxamine‐Mediated Iron‐Uptake System in Vibrio vulnificus
Kim, C., Park, Y., & Shin, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/523108 · Cited by 49
Self-citationKim, H.-J., Kim, Y.-T., Kim, H. B., Choi, S. H., & Lee, J.-H. (2020) · Food Microbiology · doi:10.1016/j.fm.2020.103630 · Cited by 49
Role of Iron in Human Serum Resistance of the Clinical and Environmental Vibrio vulnificus Genotypes
Bogard, R. W., & Oliver, J. D. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01551-07 · Cited by 58
“which allow for the use of transferrin-bound iron (7, 11, 13, 19, 20).”
BackgroundÇam, S., & Brınkmeyer, R. (2019) · Folia Microbiologica · doi:10.1007/s12223-019-00761-9 · Cited by 52
The role of Vibrio vulnificus virulence factors and regulators in its infection-induced sepsis
Li, G., & Wang, M. (2019) · Folia Microbiologica · doi:10.1007/s12223-019-00763-7 · Cited by 50
Neupane, G. P., & Kim, D. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02186.x · Cited by 42
“vulnificus can use DFO for efficient iron uptake via the outer membrane receptor DesA, encoded by the DesA gene, under iron-limited in vitro and ex vivo conditions.(7,17,18) V.”
BackgroundEffect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
Kim, C.-M., & Shin, S.-H. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.2.289 · Cited by 42
“vulnificus; the latter two are considered archetypal ferrophilic or iron-sensitive bacteria that require higher levels of available iron for growth than other bacteria (26, 39).”
BackgroundSelf-citationHoeft, K., Bloch, D. B., Graw, J. A., Malhotra, R. K., Ichinose, F., & Bagchi, A. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001653 · Cited by 44
Adverse events following immunization: perception and evidence
Bonhoeffer, J., & Heininger, U. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32811ebfb0 · Cited by 42
Neupane, G. P., & Kim, D.-M. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0875-5 · Cited by 29
“vulnificus in susceptible patients [9].”
Proteomic analysis of Vibrio vulnificus M2799 grown under iron-repleted and iron-depleted conditions
Miyamoto, K., Kosakai, K., Ikebayashi, S., Tsuchiya, T., Yamamoto, S., & Tsujibo, H. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2008.12.004 · Cited by 28
Kim, C., Chung, Y., & Shin, S. (2009) · The Journal of Infectious Diseases · doi:10.1086/600869 · Cited by 25
Self-citationPathogenic Mechanism of Vibrio Vulnificus Infection
Lu, K., Li, Y., Chen, R., Yang, H., Wang, Y., Xiong, W., Xu, F., Yuan, Q., Liang, H., Xiao, X., et al. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0243 · Cited by 25
Kim, C., & Shin, S. H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.632 · Cited by 15
Self-citationCyclic AMP-receptor protein activates aerobactin receptor IutA expression in Vibrio vulnificus
Kim, C., Kim, S., & Shin, S. (2012) · The Journal of Microbiology · doi:10.1007/s12275-012-2056-y · Cited by 14
Self-citationCaruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yañez, J. M., et al. (2020) · Veterinary Research · doi:10.1186/s13567-020-00845-2 · Cited by 14
Selvaraj, C., Vierra, M., Dinesh, D. C., Abhirami, R., & Singh, S. K. (2021) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.02.001 · Cited by 14
Kim, D., Cho, H. S., Kang, J.-I., Kim, H. S., & Park, C. Y. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.08.003 · Cited by 10
“On the other hand, it has been reported that other iron-chelating agents such as deferasirox or deferiprone, do not act as siderophores and thus can depress the growth of ferophilic organisms.(12) Interestingly, the present patient’s initial skin lesion was on the very right forearm where deferoxamine was injected int…”
BackgroundIron-mediated regulation of metalloprotease VvpE production in Vibrio vulnificus.
Kim, C., Kim, S.-C., & Shin, S. (2012) · PubMed · Cited by 11
Self-citationKim, C., Ahn, Y.-J., Kim, S., Yoon, D.-H., & Shin, S. (2016) · Current Microbiology · doi:10.1007/s00284-016-1026-8 · Cited by 10
Self-citationRegina, V. R., Noorian, P., Sim, C. B. W., Constancias, F., Kaliyamoorthy, E., Booth, S. C., Espinoza-Vergara, G., Rice, S. A., & McDougald, D. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.01665-21 · Cited by 10
“vulnificus is ferrophilic, and iron plays a key role in pathogenicity (29, 40).”
BackgroundRegina, V. R., Noorian, P., Bo Wen, C., Constancias, F., Kaliyamoorthy, E., Booth, S. C., Espinoza-Vergara, G., Rice, S., & McDougald, D. (2021) · UTS ePRESS (University of Technology Sydney) · Cited by 9
A case report of Vibrio vulnificus sepsis in a diabetic patient
Li, J., Liao, W., Jiang, M., Cui, X., Shao, F., Ge, Z., Ji, H., & Qian, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16521 · Cited by 6
Chaer, F. E., Holtzman, N. G., Baer, M. R., Zimrin, A. B., & Law, J. Y. (2018) · Acta Haematologica · doi:10.1159/000488754 · Cited by 6
Kim, S.-P., Lee, G.-W., Kim, C., & Shin, S. (2012) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2012.42.4.294 · Cited by 6
“vulnificus is a ferrophilic bacterium that requires higher levels of readily available iron for growth initiation than other pathogens (6).”
BackgroundSelf-citationBharathan, A., Arafath, Y., Fathima, A., Hassan, S., Singh, P., Kiran, G. S., & Selvin, J. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107591 · Cited by 3
Multiple High-affinity Iron-uptake Systems ofVibrio vulnificus
Shin, S. (2013) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2013.43.3.168 · Cited by 2
Self-citationVirulence Characteristics of Sucrose-fermenting Vibrio vulnificus Strains
Kim, S., Kim, C., & Shin, S. (2010) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2010.30.5.507 · Cited by 2
“vulnificus strains to utilize transferrin-bound iron (TBI), the 6 mol/L urea-gel electrophoresis was performed, as described in our previous study [11].”
BackgroundMethodSelf-citationÇam, S. (2020) · Etlik Veteriner Mikrobiyoloji Dergisi · doi:10.35864/evmd.788440 · Cited by 2
Kim, S. Y., Chung, H. Y., Kwon, J.-G., Choi, S. H., & Lee, J.-H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.645860 · Cited by 1
Regulation of iron-uptake systems in Vibrio vulnificus, a ferrophilic bacterium
Shin, S. (2021) · Medical Biological Science and Engineering · doi:10.30579/mbse.2021.4.2.69 · Cited by 1
“vulnificus is a ferrophilic or Fe-sensitive bacterium that requires higher levels of soluble Fe for growth than other pathogenic bacteria do [28,29].”
BackgroundSelf-citationGastrointestinal Mucormycosis and Presumptive Vibriosis in a Welder, a Case Report
Reddy, A. K., & Tuznik, N. M. (2023) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-023-01428-w · Cited by 1
Current status and future prospects in a pathogenic study of Vibrio vulnificus
Kashimoto, T. (2010) · Nippon Saikingaku Zasshi · doi:10.3412/jsb.65.369
Kim, C., Kim, S.-C., & Shin, S. (2011) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2011.41.2.91
“bacteria (22); that is to say, cirrhotic ascites may be still an iron-limited condition for the ferrophilic bacterium V.”
BackgroundSelf-citationCaruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161491
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161458
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161485
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161479
Pathogenic Mechanisms of V. vulnificus and Its Role in the Development of Sepsis
Yu, Z., Zhu, X., Tang, S., Yang, S. Q., Li, J., Luo, L., Tan, Y., & Yin, J. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70343
Metadata
- Authors
- Kim, C., Park, R., Choi, M., Sun, H., & Shin, S.
- Affiliations
- Chosun University (KR)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01
- Volume
- 195
- Issue
- 1
- Pages
- 90-98
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2132560344
- Cited by
- 46
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2021: 5 · 2020: 7 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Vibrio bacteria research studies
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Vibrio vulnificus, iron acquisition, non-transferrin-bound iron, transferrin-bound iron, iron chelation therapy, deferiprone, siderophores, iron absorption, bacterial growth, infection control
- MeSH terms
- Bacterial Proteins, Ferric Compounds, Iron, Iron Chelating Agents, Repressor Proteins, Transferrin, Vibrio vulnificus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.